Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease

Parkinson's disease (PD) is a growing burden worldwide, and there is no reliable biomarker used in clinical routines to date. Cerebrospinal fluid (CSF) is routinely collected in patients with neurological symptoms and should closely reflect alterations in PD patients’ brains. Here, we describe...

Full description

Bibliographic Details
Main Authors: Karayel, O. (Author), Kuras, Y.I (Author), Mann, M. (Author), Merchant, K. (Author), Padmanabhan, S. (Author), Scherzer, C.R (Author), Tuncali, I. (Author), Virreira Winter, S. (Author), Vu, D.T (Author), Wills, A.-M (Author)
Format: Article
Language:English
Published: Cell Press 2022
Subjects:
biomarker
CSF
DIA
LRRK2
mass spectrometry
Parkinson's disease
proteomics
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items